Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study

British Journal of Haematology

Volumn 175, Issue 3, 2016, Pages 462-466

  Thompson, Philip A ^a   Lévy, Vincent ^b   Tam, Constantine S ^c   Al Nawakil, Chadi ^b   Goudot, François Xavier ^b   Quinquenel, Anne ^d   Ysebaert, Loic ^e   Michallet, Anne Sophie ^f   Dilhuydy, Marie Sarah ^g   Van Den Neste, Eric ^h   Dupuis, Jehan ⁱ   Keating, Michael J ^a   Meune, Christophe ^b   Cymbalista, Florence ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITÉ PARIS 13   (France)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d SERVICE DE DERMATOLOGIE   (France)

^e Service D'Hematologie IUC Toulouse Oncopole   (France)

^f CENTRE LÉON BÉRARD   (France)

^g HAUT LÉVÊQUE HOSPITAL   (France)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ HENRI MONDOR HOSPITAL   (France)

Author keywords

atrial fibrillation; chronic lymphocytic leukaemia; ibrutinib

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; FLECAINIDE; IBRUTINIB; LOW MOLECULAR WEIGHT HEPARIN; RITUXIMAB; ANTINEOPLASTIC AGENT; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHRONIC LYMPHATIC LEUKEMIA; CONGESTIVE HEART FAILURE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FLUTTER; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PAROXYSMAL ATRIAL FIBRILLATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TACHYCARDIA; THROMBOEMBOLISM; VALVULAR HEART DISEASE; CLINICAL TRIAL; COMPLICATION; DISEASE MANAGEMENT; HEMORRHAGE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MIDDLE AGED; MULTICENTER STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ATRIAL FIBRILLATION; DISEASE MANAGEMENT; FEMALE; HEMORRHAGE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIMIDINES; RETROSPECTIVE STUDIES;

EID: 84992463341     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14324     Document Type: Article

References (12)

1. Burger, J.A., Tedeschi, A., Barr, P.M., Robak, T., Owen, C., Ghia, P., Bairey, O., Hillmen, P., Bartlett, N.L., Li, J., Simpson, D., Grosicki, S., Devereux, S., McCarthy, H., Coutre, S., Quach, H., Gaidano, G., Maslyak, Z., Stevens, D.A., Janssens, A., Offner, F., Mayer, J., O'Dwyer, M., Hellmann, A., Schuh, A., Siddiqi, T., Polliack, A., Tam, C.S., Suri, D., Cheng, M., Clow, F., Styles, L., James, D.F. & Kipps, T.J.; RESONATE-2 Investigators. (2015) Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia. New England Journal of Medicine, 373, 2425–2437.
2. Byrd, J.C., Brown, J.R., O'Brien, S., Barrientos, J.C., Kay, N.E., Reddy, N.M., Coutre, S., Tam, C.S., Mulligan, S.P., Jaeger, U., Devereux, S., Barr, P.M., Furman, R.R., Kipps, T.J., Cymbalista, F., Pocock, C., Thornton, P., Caligaris-Cappio, F., Robak, T., Delgado, J., Schuster, S.J., Montillo, M., Schuh, A., de Vos, S., Gill, D., Bloor, A., Dearden, C., Moreno, C., Jones, J.J., Chu, A.D., Fardis, M., McGreivy, J., Clow, F., James, D.F. & Hillmen, P.; RESONATE Investigators. (2014) Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. New England Journal of Medicine, 371, 213–223.
3. Chanan-Khan, A.A., Cramer, P., Demirkan, F., Fraser, G., Silva, R.S. & Pylypenko, H. (2015) Ibrutinib combined with bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): first results from a randomized, double-blind, placebo-controlled, phase III study. Journal of Clinical Oncology, 33(Suppl.), abstract LBA7005.
4. Farooqui, M., Valdez, J., Soto, S., Bray, A., Tian, X. & Wiestner, A. (2015) Atrial fibrillation in CLL/SLL patients on ibrutinib. Blood, 126, 2933.
5. Friberg, L., Rosenqvist, M. & Lip, G.Y. (2012) Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. European Heart Journal, 33, 1500–1510.
6. Jain, P., Keating, M., Wierda, W., Estrov, Z., Ferrajoli, A., Jain, N., George, B., James, D., Kantarjian, H., Burger, J. & O'Brien, S. (2015) Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib. Blood, 125, 2062–2067.
7. Kamel, S., Horton, L., Ysebaert, L., Levade, M., Burbury, K., Tan, S., Cole-Sinclair, M., Reynolds, J., Filshie, R., Schischka, S., Khot, A., Sandhu, S., Keating, M.J., Nandurkar, H. & Tam, C.S. (2015) Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation. Leukemia, 29, 783–787.
8. Levade, M., David, E., Garcia, C., Laurent, P.A., Cadot, S., Michallet, A.S., Bordet, J.C., Tam, C., Sié, P., Ysebaert, L. & Payrastre, B. (2014) Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions. Blood, 124, 3991–3995.
9. Lip, G.Y., Nieuwlaat, R., Pisters, R., Lane, D.A. & Crijns, H.J. (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137, 263–272.
10. Maddocks, K.J., Ruppert, A.S., Lozanski, G., Heerema, N.A., Zhao, W., Abruzzo, L., Lozanski, A., Davis, M., Gordon, A., Smith, L.L., Mantel, R., Jones, J.A., Flynn, J.M., Jaglowski, S.M., Andritsos, L.A., Awan, F., Blum, K.A., Grever, M.R., Johnson, A.J., Byrd, J.C. & Woyach, J.A. (2015) Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia. JAMA Oncology, 1, 80–87.
11. McMullen, J.R., Boey, E.J.H., Ooi, J.Y.Y., Seymour, J.F., Keating, M.J. & Tam, C.S. (2014) Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling. Blood, 124, 3829–3830.
12. Shanafelt, T.D., Chaffee, K.G., Call, T.G., Parikh, S.A., Schwager, S.M., Ding, W., Leis, J.F., Chanan-Khan, A., Slager, S.L. & Kay, N.E. (2015) Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Blood, 126, 2950.